Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Baxter International (NY:BAX)

24.98 -0.30 (-1.21%)
Delayed Quote Updated: 2:23 PM EDT, Oct 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Baxter International

< Previous 1 2
...
11 12 13 14 15 16 17 18 19
...
27 28 Next >
News headline image
Baxter to Present at 7th Annual Evercore HealthCONx Conference
From Baxter International Inc.
Via Business Wire
News headline image
Baxter to Present at Jefferies London Healthcare Conference
From Baxter International Inc.
Via Business Wire
News headline image
Baxter to Present at Stifel 2024 Healthcare Conference
From Baxter International Inc.
Via Business Wire
News headline image
Baxter Declares Quarterly Dividend
From Baxter International Inc.
Via Business Wire
News headline image
Uncovering Potential: Baxter Intl's Earnings Preview ↗
 
Via Benzinga
News headline image
3 Shareholder Yield Stocks For Growth And Dividends ↗
Top shareholder yield stocks are generating returns by paying dividends, buying back stock, and reducing debt. 
Via Talk Markets
News headline image
Beyond The Numbers: 6 Analysts Discuss Baxter Intl Stock ↗
 
Via Benzinga
News headline image
Baxter Expects Hurricane Helene Aftermath To Impact Near-Term Financial Outlook ↗
Baxter International's Q3 2024 adjusted EPS of $0.80 beat estimates, driven by strong Medical Products & Therapies sales and improved supply chain management. 
Via Benzinga
Topics Economy
News headline image
Baxter Reports Third-Quarter 2024 Results
From Baxter International Inc.
Via Business Wire
News headline image
Baxter to Present at UBS Global Healthcare Conference
From Baxter International Inc.
Via Business Wire
News headline image
US Hospitals Face Critical IV Fluid Shortage After Baxter Facility Shuts Down Due To Hurricane Helene ↗
The U.S. faces a critical shortage of IV fluids due to Hurricane Helene's damage to Baxter's North Carolina plant, forcing hospitals to delay surgeries. Federal efforts to rebuild and import supplies... 
Via Benzinga
News headline image
Baxter to Host Third-Quarter 2024 Financial Results Conference Call for Investors
From Baxter International Inc.
Via Business Wire
News headline image
“Jackets And Packets” Stock Market (And Sentiment Results) ↗
Revenues continue to grow, Free Cash Flow recovering, Margins high, Stock Price subdued. 
Via Talk Markets
News headline image
Baxter's North Carolina Plant Recovery Underway After Hurricane Flooding, Starts Product Imports ↗
Baxter International resumes IV fluid shipments from international sites after Hurricane Helene disrupted production at its North Carolina plant, which supplies 60% of U.S. IV fluids. FDA approves... 
Via Benzinga
News headline image
Baxter's North Carolina Facility Manufactures ~60% Of IV Fluids And Peritoneal Dialysis Solutions, Senator Demands Immediate Action To Protect Patient Care Amid Shortage ↗
U.S. Senator Amy Klobuchar has called on HHS Secretary Xavier Becerra to address the national IV solution shortage following the closure of Baxter's facility due to Hurricane Helene, which compromises... 
Via Benzinga
News headline image
Hurricane Helene Economic Price Tag Could Be $34 Billion; The Stock Market Impact ↗
Moody's Analytics projects major costs. 
Via Investor's Business Daily
News headline image
Hurricane Helene Shutters Baxter International's Key Manufacturing Hub In North Carolina ↗
Baxter International shuts down its largest manufacturing facility in North Carolina due to Hurricane Helene's damage. Shares fall. 
Via Benzinga
News headline image
Baxter Provides Update on North Cove, N.C., Facility and Hurricane Helene Relief Plans for Community
From Baxter International Inc.
Via Business Wire
News headline image
The Latest Analyst Ratings For Baxter Intl ↗
 
Via Benzinga
News headline image
Medtronic Inc. Dividend Stock Analysis - Sunday, Sept. 29 ↗
Medtronic Inc. is a global medical device manufacturer with leadership positions in the pacemaker, defibrillator, orthopedic, diabetes management, and other medical markets. Here are some highlights... 
Via Talk Markets
News headline image
Baxter Launches Next Generation of The Vest System for Airway Clearance
From Baxter International Inc.
Via Business Wire
News headline image
Baxter Appoints Jeffrey A. Craig to Its Board
From Baxter International Inc.
Via Business Wire
News headline image
Medtronic Recalls Some Video Laryngoscopes Due To Increased Risk For Battery Overheat, Explosion ↗
Medtronic recalls devices over battery risks that could lead to explosions and updates usage instructions. 
Via Benzinga
Topics Product Recall
News headline image
Baxter to Present at 2024 Wells Fargo Healthcare Conference
From Baxter International Inc.
Via Business Wire
News headline image
Rivian, Chipotle Mexican And Sirius XM Are Among Top 10 Large Cap Losers Last Week (Aug 11-Aug 17): Are The Others In Your Portfolio? ↗
Ten large-cap stocks were the worst performers last week, with TME, MBLY, RIVN, CMG, LINE, SIRI, HSY, BAX, BR, and UTHR all seeing declines. 
Via Benzinga
News headline image
Baxter Tumbles On $3.8 Billion Kidney Deal — Why Investors Expected More ↗
The company is selling its Vantive Kidney Care business to Carlyle, a private equity investor in the medtech space. 
Via Investor's Business Daily
News headline image
Baxter Seals $3.8B Deal With Carlyle For Its Kidney Care Segment ↗
Baxter has agreed to sell its Kidney Care segment to Carlyle for $3.8 billion. Baxter will receive about $3.5 billion in cash, with net after-tax proceeds estimated at $3 billion. Post-sale, Baxter... 
Via Benzinga
News headline image
Baxter Announces Definitive Agreement to Divest Its Vantive Kidney Care Segment to Carlyle for $3.8 Billion
From Baxter International Inc.
Via Business Wire
News headline image
BAX Stock Earnings: Baxter Intl Beats EPS, Beats Revenue for Q2 2024 ↗
BAX stock results show that Baxter Intl beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
Baxter Lifts Annual Outlook After Strong Q2 Beat, Medical Devices Sales ↗
Baxter surpasses Q2 expectations with adjusted EPS of $0.68 and sales of $3.812 billion. Sales rose 3% reported and 4% constant currency, driven by Pharmaceuticals, Medical Products, and Healthcare... 
Via Benzinga
< Previous 1 2
...
11 12 13 14 15 16 17 18 19
...
27 28 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.